BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zipprich HM, Teschner U, Witte OW, Schönenberg A, Prell T. Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany. J Clin Med 2020;9:E1643. [PMID: 32486074 DOI: 10.3390/jcm9061643] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Santos-García D, Oreiro M, Pérez P, Fanjul G, Paz González JM, Feal Painceiras MJ, Cores Bartolomé C, Valdés Aymerich L, García Sancho C, Castellanos Rodrigo MDM. Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients. Mov Disord 2020;35:1712-6. [PMID: 32776601 DOI: 10.1002/mds.28261] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
2 El-Qushayri AE, Ghozy S, Reda A, Kamel AMA, Abbas AS, Dmytriw AA. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis. Rev Med Virol 2021;:e2278. [PMID: 34260773 DOI: 10.1002/rmv.2278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Feeney MP, Xu Y, Surface M, Shah H, Vanegas-Arroyave N, Chan AK, Delaney E, Przedborski S, Beck JC, Alcalay RN. The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey study. NPJ Parkinsons Dis 2021;7:10. [PMID: 33479241 DOI: 10.1038/s41531-020-00153-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
4 Litke N, Daniel T, Wallacher S, Cordes L, Henning D, Schmidt E, Doll L, Wensing M. [Impact of the COVID-19 pandemic on outpatient physical therapy in Germany]. Z Evid Fortbild Qual Gesundhwes 2021:S1865-9217(21)00119-7. [PMID: 34384716 DOI: 10.1016/j.zefq.2021.07.002] [Reference Citation Analysis]
5 Fearon C, Fasano A. Parkinson's Disease and the COVID-19 Pandemic. J Parkinsons Dis 2021;11:431-44. [PMID: 33492244 DOI: 10.3233/JPD-202320] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
6 Zalyalova ZA, Khasanova DM. [Risk and course of COVID-19 in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:152-6. [PMID: 34693704 DOI: 10.17116/jnevro2021121091152] [Reference Citation Analysis]
7 Almeida LRS, Piemonte MEP, Cavalcanti HM, Canning CG, Paul SS. A Self-Reported Clinical Tool Predicts Falls in People with Parkinson's Disease. Mov Disord Clin Pract 2021;8:427-34. [PMID: 33816673 DOI: 10.1002/mdc3.13170] [Reference Citation Analysis]
8 Fründt O, Hanff A, Mai T, Kirchner C, Bouzanne des Mazery E, Amouzandeh A, Buhmann C, Krüger R, Südmeyer M. Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD). Brain Sciences 2022;12:62. [DOI: 10.3390/brainsci12010062] [Reference Citation Analysis]
9 Cavallieri F, Sireci F, Fioravanti V, Toschi G, Rispoli V, Antonelli F, Costantini M, Ghirotto L, Valzania F. Parkinson's disease patients' needs during the COVID-19 pandemic in a red zone: A framework analysis of open-ended survey questions. Eur J Neurol 2021. [PMID: 33460507 DOI: 10.1111/ene.14745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mackensen S, Halimeh S, Siebert M, Wermes C, Hassenpflug W, Holstein K, Olivieri M. Impact of COVID‐19 pandemic on mental health of patients with inherited bleeding disorders in Germany. Haemophilia 2020;26. [DOI: 10.1111/hae.14130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fabbri M, Leung C, Baille G, Béreau M, Brefel Courbon C, Castelnovo G, Carriere N, Damier P, Defebvre L, Doe de Maindreville A, Fluchere F, Fuzzatti M, Grabli D, Maltete D, Rousseau V, Sommet A A, Thalamas C, Thiriez C, Rascol O, Ory-Magne F. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study. Parkinsonism Relat Disord 2021;89:128-33. [PMID: 34293534 DOI: 10.1016/j.parkreldis.2021.07.013] [Reference Citation Analysis]
12 van der Heide A, Meinders MJ, Bloem BR, Helmich RC. The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson's Disease. J Parkinsons Dis 2020;10:1355-64. [PMID: 32925108 DOI: 10.3233/JPD-202251] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
13 Anghelescu BA, Bruno V, Martino D, Roach P. Effects of the COVID-19 Pandemic on Parkinson's Disease: a Single-Centered Qualitative Study. Can J Neurol Sci 2021;:1-13. [PMID: 33843516 DOI: 10.1017/cjn.2021.70] [Reference Citation Analysis]
14 Kitani-Morii F, Kasai T, Horiguchi G, Teramukai S, Ohmichi T, Shinomoto M, Fujino Y, Mizuno T. Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan. PLoS One 2021;16:e0245864. [PMID: 33481879 DOI: 10.1371/journal.pone.0245864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zipprich HM, Schönenberg A, Teschner U, Prell T. Changes of perceptions and behaviours during the phases of COVID-19 pandemic in German elderly people with neurological disorders: an observational study using telephone interviews. BMJ Open 2021;11:e045780. [PMID: 33436478 DOI: 10.1136/bmjopen-2020-045780] [Reference Citation Analysis]
16 D'souza J, Biswas A, Gada P, Mangroliya J, Natarajan M. Barriers leading to increased disability in neurologically challenged populations during COVID-19 pandemic: a scoping review. Disabil Rehabil 2021;:1-14. [PMID: 34666575 DOI: 10.1080/09638288.2021.1986747] [Reference Citation Analysis]
17 Lebrasseur A, Fortin-Bédard N, Lettre J, Raymond E, Bussières EL, Lapierre N, Faieta J, Vincent C, Duchesne L, Ouellet MC, Gagnon E, Tourigny A, Lamontagne MÈ, Routhier F. Impact of the COVID-19 Pandemic on Older Adults: Rapid Review. JMIR Aging 2021;4:e26474. [PMID: 33720839 DOI: 10.2196/26474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Clavel N, Badr J, Gautier L, Lavoie-Tremblay M, Paquette J. Risk Perceptions, Knowledge and Behaviors of General and High-Risk Adult Populations Towards COVID-19: A Systematic Scoping Review. Public Health Rev 2021;42:1603979. [PMID: 34909234 DOI: 10.3389/phrs.2021.1603979] [Reference Citation Analysis]
19 Volot F, Soudry-Faure A, Callegarin A, Ksiazek E, Delienne S, Cottin Y, Maynadié M, Boulin M. Impact of first COVID-19 lockdown on paediatric and adult haemophilia patients treated in a French Haemophilia Comprehensive Care Centre. Haemophilia 2022. [PMID: 35238436 DOI: 10.1111/hae.14526] [Reference Citation Analysis]
20 Silva-Batista C, Coelho DB, Júnior RCF, Almeida LR, Guimarães A, Nóbrega KCC, Machado Sanchez H, Lindquist ARR, Israel VL, Kanegusuku H, Guimarães R, Beckmann Bosaipo N, Barbosa R, Correa CL, Finatto MJ, Mendes FADS, Piemonte MEP. Multidimensional Factors Can Explain the Clinical Worsening in People With Parkinson's Disease During the COVID-19 Pandemic: A Multicenter Cross-Sectional Trial. Front Neurol 2021;12:708433. [PMID: 34393984 DOI: 10.3389/fneur.2021.708433] [Reference Citation Analysis]
21 Brooks SK, Weston D, Greenberg N. Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review. Public Health 2021;199:77-86. [PMID: 34571441 DOI: 10.1016/j.puhe.2021.08.014] [Reference Citation Analysis]
22 Scherbaum R, Kwon EH, Richter D, Bartig D, Gold R, Krogias C, Tönges L. Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany. Mov Disord 2021;36:1049-57. [PMID: 33942924 DOI: 10.1002/mds.28586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Pelicioni PHS, Schulz-Moore JS, Hale L, Canning CG, Lord SR. Lockdown During COVID-19 and the Increase of Frailty in People With Neurological Conditions. Front Neurol 2020;11:604299. [PMID: 33304316 DOI: 10.3389/fneur.2020.604299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Davison KM, Thakkar V, Lin SL, Stabler L, MacPhee M, Carroll S, Collins B, Rezler Z, Colautti J, Xu CC, Fuller-Thomson E, Hey B, Kelly K, Mullaly L, Remick R, Ravindran A, Paric A, D'Andreamatteo C, Smye V. Interventions to Support Mental Health among Those with Health Conditions That Present Risk for Severe Infection from Coronavirus Disease 2019 (COVID-19): A Scoping Review of English and Chinese-Language Literature. Int J Environ Res Public Health 2021;18:7265. [PMID: 34299716 DOI: 10.3390/ijerph18147265] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, Socorro de Barros Viana G. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? Rev Neurosci 2021;32:235-47. [PMID: 33185582 DOI: 10.1515/revneuro-2020-0074] [Reference Citation Analysis]
26 Wolff AW, Haller B, Demleitner AF, Westenberg E, Lingor P. Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study. Brain Sciences 2022;12:353. [DOI: 10.3390/brainsci12030353] [Reference Citation Analysis]
27 Geleta TA, Deriba BS, Beyane RS, Mohammed A, Birhanu T, Jemal K. COVID-19 Pandemic Preparedness and Response of Chronic Disease Patients in Public Health Facilities. Int J Gen Med 2020;13:1011-23. [PMID: 33177864 DOI: 10.2147/IJGM.S279705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 de Rus Jacquet A, Bogard S, Normandeau CP, Degroot C, Postuma RB, Dupré N, Miyasaki JM, Monchi O, Martino D, Fon EA, Cicchetti F. Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience. Parkinsonism Relat Disord 2021;91:66-76. [PMID: 34536727 DOI: 10.1016/j.parkreldis.2021.08.018] [Reference Citation Analysis]
29 Cheong JL, Goh ZHK, Marras C, Tanner CM, Kasten M, Noyce AJ; Movement Disorders Society Epidemiology Study Group. The Impact of COVID-19 on Access to Parkinson's Disease Medication. Mov Disord 2020;35:2129-33. [PMID: 32860226 DOI: 10.1002/mds.28293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]